Braun Stacey Associates Inc. Sells 1,391 Shares of Danaher Co. (NYSE:DHR)

Braun Stacey Associates Inc. cut its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 84,616 shares of the conglomerate's stock after selling 1,391 shares during the period. Braun Stacey Associates Inc.'s holdings in Danaher were worth $19,424,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of DHR. AMF Tjanstepension AB bought a new stake in Danaher during the 3rd quarter worth approximately $5,923,000. Creative Planning grew its position in Danaher by 3.1% during the 3rd quarter. Creative Planning now owns 126,340 shares of the conglomerate's stock worth $35,125,000 after acquiring an additional 3,749 shares during the last quarter. Good Life Advisors LLC bought a new position in Danaher in the 3rd quarter valued at $217,000. Howard Capital Management Group LLC boosted its position in Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock valued at $342,000 after buying an additional 48 shares during the last quarter. Finally, Cyndeo Wealth Partners LLC boosted its position in Danaher by 9.7% in the 3rd quarter. Cyndeo Wealth Partners LLC now owns 8,425 shares of the conglomerate's stock valued at $2,342,000 after buying an additional 748 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on DHR. Jefferies Financial Group decreased their price objective on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Raymond James reiterated a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. StockNews.com lowered Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Royal Bank of Canada reiterated an "outperform" rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Finally, JPMorgan Chase & Co. decreased their price objective on Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $278.00.

Danaher Trading Up 0.9 %

Danaher stock traded up $1.91 during mid-day trading on Friday, hitting $209.86. 6,209,935 shares of the company's stock were exchanged, compared to its average volume of 4,574,762. The firm has a market capitalization of $151.58 billion, a P/E ratio of 39.75, a PEG ratio of 2.61 and a beta of 0.83. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company's 50 day simple moving average is $226.71 and its 200-day simple moving average is $247.11.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm posted $2.09 EPS. On average, equities analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is a boost from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio is 20.45%.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.